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Patient satisfaction surveys may not adequately reflect organizations that conduct research in patients who enroll in 
clinical trials. The purpose of this systematic literature review was to summarize the current state of knowledge of patient 
satisfaction while enrolled in clinical trials utilizing a widely used, validated patient satisfaction instrument. A 
comprehensive literature search was conducted using CINAHL, EMBASE, PsycInfo, PubMed and Web of Science. 
Studies were evaluated in terms of clinical trial participation; assessment conducted during or after participation; 
utilization of a validated instrument; a pharmacological intervention; and the paper was published in English. Only nine 
studies met this review’s inclusion criteria. Eight studies utilized investigator-developed patient satisfaction instruments 
and only one study used a widely-used, validated patient satisfaction instrument. Two studies evaluated patient 
satisfaction during the development of the instrument. Of the nine studies identified, only five patient satisfaction 
domains were common across the studies and only study evaluated the associations of patient satisfaction responses with 
clinical outcomes. Given the importance of patient satisfaction surveys, future studies need to focus on this subset of 
patients enrolled in clinical trials to evaluate a patient’s experience and its impact on protocol compliance and protocol 
outcomes. Future studies need to focus on domains associated with clinical trial participation and look beyond the 
current patients’ general expectations about healthcare accessibility, facilities, healthcare team clinical skills, and their 
ability to focus and listen to the patients’ concerns. 
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Today, healthcare organizations are faced with evaluating 
quality indicators derived from scores reported by patients 
on the Hospital Consumer Assessment of Healthcare 
Providers and Systems (HCAHPS) survey or its approved 
equivalent.1 These scores provide insight into 
understanding the patients’ perspective on the delivery of 
care.2 However, the information obtained from these 
surveys may not entirely reflect organizations that conduct 
clinical research, as the surveys may not adequately capture 
the experience of patients enrolled in clinical trials. 
 
Healthcare organizations engaged in clinical trials are 
significant contributors to the development of new 
discoveries.3 Clinical trials are recognized by healthcare 
professionals, policy makers and the public at large as 
beneficial to advancing science and treatment options for 
existing and future patients.4 The success of clinical trials is 
dependent upon patient participation and their overall 
experience.5  
 
Findings regarding treatment compliance of patients in 
clinical trials have suggested that evaluating patient 
behavior and experience is one of the most important 
activities researchers can perform.6-8 However, the 
majority of these studies have focused on adherence to 
clinic appointments, taking medication or following 
specific study activities (e.g., diet, exercise).6,9 Therefore, 
evaluating for positive patient experiences in a clinical trial 
may lead to compliance with treatment, which can be an 
important determinant for the outcome of a clinical trial.7 
Additional research is warranted to evaluate the entire 
patient encounter with the healthcare team, as well as their 
compliance to a protocol, which may be more reflective of 
a patient’s satisfaction with a clinical trial. 
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While scientists continue to translate their bench research 
into clinical trials,10 no studies were identified that 
evaluated for patient satisfaction in a clinical trial utilizing a 
widely used, validated clinical trial patient satisfaction 
instrument. Therefore, this review focused on studies of 
patient satisfaction with their own research experience 
while enrolled in a clinical trial, evaluated by utilizing a 
widely used, validated patient satisfaction instrument as an 
initial effort to describe their experiences. When patients 
do not feel satisfied with their clinical trial experience, they 
may choose to prematurely discontinue participation in a 
trial, compromising the study’s validity.7,11 Therefore, the 
evaluation of patient satisfaction in a clinical trial is an 
important strategy in overcoming challenges experienced 
in research.  
 
Patients enrolled in clinical trials will continue to be a 
salient part of the equation for accelerating advancements 
in new treatments and medicine. However, the limited 
amount of research with patient satisfaction while enrolled 
in pharmacological medical intervention clinical trials may 
influence research protocol outcomes without evaluating a 
patient’s experience and its impact on protocol 
compliance. No comprehensive review has summarized 
the findings from studies utilizing a widely used, validated 
patient satisfaction instrument that evaluated associations 
between patient satisfaction and clinical trials experience. 
Therefore, the purposes of this review are to: 1) describe 
the most common patient satisfaction instrument; 2) 
describe the most common patient satisfaction domains 
measuring the experience reported; and 3) summarize the 
associations identified between patient satisfaction and 
clinical trial experience. We hypothesized that positive 
patient satisfaction scores when enrolled in a clinical trial 
would influence protocol compliance and lead to well-





For this review, a systematic electronic literature search 
was conducted using Cumulative Index to Nursing and 
Allied Health Literature (CINAHL®), Excerpta Medica 
Database (EMBASE®), PsycInfo®, PubMed® and Web 
of Science® databases. Key words used when searching 
the databases were patient satisfaction AND clinical trial AND 
clinical research AND clinical study. The initial search yielded 9 
studies identified in CINAHL, 8,400 studies identified in 
EMBASE®, 6 studies in PsycINFO®, 7,051 studies 
identified in PubMed®, and 510 studies in Web of 
Science®.  Studies were included if they met all of the 
following inclusion criteria: (a) participants enrolled in a 
clinical trial, (b) patient satisfaction assessment conducted 
during or after the trial, (c) utilization of a validated patient 
satisfaction instrument, (d) a pharmacological medical 
intervention was utilized in the clinical trial and, (e) the 
paper was published in English. 
 
Inclusion and Exclusion Criteria 
As shown in Figure 1, in the final search, after removing 
for duplicate articles across the databases and studies that 
did not meet the inclusion criteria, nine unique studies 




Records identified through database 
searching 
n = 9 CINAHL 
n = 8,400 Embase  
n = 6 PsycINFO  
n = 7,051 PubMed  
n = 510 Web of Science 
 
Full-text articles 
assessed for eligibility 
(n = 13,796) 
Records excluded  
(n = 2,180) 
Records screened  
(n = 12) 
Full-text articles 
excluded 
(n = 3) 
Studies included in 
quantitative synthesis 
(n = 9) 
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were identified.12-20 The majority of the studies were 
removed from the analysis because they focused on patient 
motivation/satisfaction before the initiation of a clinical 
trial, non-pharmacological medical interventions (e.g., 
behavioral, dentistry, medical devices), qualitative studies, 
or assessments that did not report the utilization of a 
validated instrument.  
 
To answer the specific aims of this review, findings from 
the nine studies are summarized into two tables. Table 1 
summarizes one study16 of patient satisfaction scores in a 
clinical trial utilizing a widely used validated patient 
satisfaction instrument, and Table 2 summarizes the eight 
studies12-15,17-20 of patient satisfaction scores in a clinical 
trial utilizing an investigator-developed validated patient 
satisfaction instrument. 
 
Study Selection and Assessment 
From a methodological perspective, the following criteria 
were evaluated: author, year, purpose, study design (i.e., 
cross-sectional, longitudinal), and sample characteristics 
(i.e., sample size, age, gender, therapeutic focus, setting). 
To describe patient satisfaction, the following criteria were 
evaluated: instrument, number of items assessed, and 
patient satisfaction domains. The final objective of this 





Description of the studies 
Six of the nine studies that evaluated patient satisfaction in 
patients who participated in a clinical trial used a 
descriptive, cross-sectional design,12,14-17,19 one used an 
exploratory survey study 13 and one used a descriptive case 
study.18 Only one study used a descriptive longitudinal 
clinical trial design.20 The sample size ranged from 8012 to 
4,281.17 Across the nine studies, the age ranged from 1818 
to >8019 years and gender percentages ranged from 
38.2%13 to 81%17 female. In four of the nine 
studies,12,16,17,19 the therapeutic areas focused on clinical 
trials with specific disease states (i.e., ophthalmology, 
cardiovascular, cognitive impairment, infectious disease). 
The remaining five studies focused on clinical trials with 
various disease states.13-15,18,20 
 
Six of the nine studies were conducted in outpatient 
settings.12,14-17,19 The remaining three studies were 
conducted in both inpatient and outpatient settings.13,18,20 
Two of the nine studies evaluated patient satisfaction 
during the development of the investigator-developed 
instrument.15,18 Four were conducted in the United 
States,15-18 one study was conducted in Australia,12 one in 
the Netherlands,20 one in South Korea,13 one in Sweden,14 
Table 1. Patient Satisfaction While Enrolled in Clinical Trials Summary of Studies Utilizing A Widely Used, 
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affecting motivation 























• Research Satisfaction 






Number of Items 
Assessed: 
• 8 




health and human 
services programs. 
Questions what 
was liked most, 
what was liked 
least, and what the 
respondent would 
change about the 
study. 
• Overall satisfaction 
scores was high with 
means of each 
individual item near or 
above a value of 3 on 
a scale from 1 (worst) 
to 4 (best). 
• Individuals who 
completed the survey 
scored higher than 
those who did not on 
item responses related 
to if you had a chance 
to redo your decision 
to participate in this 
research program, as 
well as do you think 
you would choose to 
participate. 
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d one19 in multinational countries (i.e., United States, Table 2. Patient Satisfaction While Enrolled in Clinical Trials Summary of Studies Utilizing Investigator Developed 
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• Trial outcomes 
• Relationship with 
medical staff 
• Overall patient 
impression of the 
clinical trial 
• Overall impression of trial 
participation was mostly 
positive, majority of the 
patients felt that taking part 
of the trial was important 
for their condition and 
would recommend 
participation to another 
person. 
• Improved relationship with 
care provider. 
• Primary reasons for 
participation were to 
contribute to science and 
receive increased eye 
monitoring. 
Author: 
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decisions of clinical trial 
participants to enter 
research study, to 
measure participants' 
knowledge of clinical 
trials, to investigate 
participant satisfaction 
and to compare 
responses between 
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perceptions on the 
favorability, 
necessity, safety 
and willingness to 
re-participate 
• Non healthy volunteers 
were influenced by medical 
personnel regarding 
decision making process for 
participation. 
• No differences were found 
between the two groups in 
willingness to participate 
and satisfaction with clinical 
trials. 
• More than 50% thought 
their physicians could 
persuade them to 
participate or that all 
participants would receive a 
new drug or treatment. 
Author: 




To evaluate patients’ 
motivation for 
participating in phase 3 
RCTS and to find out 
how patients perceived 
the information 
concerning the trials 
and to describe their 
experiences related to 

























Number of Items: 
• 60 
 







• Most participants reported 
one major reason for 
participation in RCTs and 
some cited several reasons.  
• Results: most stated that 
‘the hope of getting 
well/slowing the disease’ 
and ‘contributing to 
research that can help 
others in the future’.  
• Majority said they were 
satisfied with the 
information they received.  
• 96% reported high levels of 
satisfaction with trial 
participation. 
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Canada). Table 2 Cont’d. Patient Satisfaction While Enrolled in Clinical Trials Summary of Studies Utilizing Investigator 
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Assessed: 
• 27 
• 3 free text options 
• Study visits 
• Study staff 
• Study 
• Future participation 
• Patient-staff 
interactions received 
the highest percentile 
ranks. 
• Facilities cleanliness 
and environment were 
well rated. 
• Questions related to 
enrolling in future 
trials, enjoying visits, 
and believing that 
medical care was 
enhanced by the study 
ranked below the 62nd 
percentile. 
Author: 
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• 10 
• Benefits from 
participation in the 
trial 
• Motivation for 
joining 
• Satisfaction with 
clinical staff and 
operations 
• Primary reasons given 
for participation were 
altruistic, contributing 
to science and helping 
to improve the health 
of others. 
• Reasons for joining 
trial differed by age, 
race, gender and 
education. 
• 93% responded yes 
and more than 98% 
would recommend 
SHEP or a similar 
program to a good 
friend. 
Author: 
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• Highly positive ratings 
regarding research 
study site experiences 
ranging from 
courteousness and 
knowledge of study 
staff to understanding 
consent and study 
procedures. 
• Overall positive 
experience rating of 
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Clinical trials and patient assessment instruments Table 2 Cont’d. Patient Satisfaction While Enrolled in Clinical Trials Summary of Studies Utilizing Investigator 
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participants enrolled in 
the GRACE clinical 
trial experiences and 
opinions about study 




























Instrument:   
• Investigator 
developed: 
      GRACE participant 
survey 
 
Number of Items 
Assessed: 
• 40 
• Open ended 
questions 
• Adherence 
• Discontinuation and 
virologic response 
rates 
• Survey participants 
experiences during 
the trial 
• Opinions about the 
trial 
• Associations of 
response with clinical 
outcomes 
• Access to treatment 
(41%) and too many 
blood draws (26%) 
were reported as the 
best and worst part of 
the study, respectively. 
• Support from study site 
staff was reported as 
the most important 
factor in completing the 
study (47%). 
• 68% would be 
interested in sharing 
their GRACE 
experience, and 96% 
would recommend 
participation in a 
clinical trial to others. 
Factors associated with 
non-adherence, study 
discontinuation, and 
poor virologic response 
were being the primary 
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• Satisfaction with 
various aspects of 
clinical trial 
participation 
• Satisfaction with own 
personal benefit and 
that of future patients 
• Satisfaction with 
medical treatment 
• Satisfaction with 
learning about one’s 
health condition 
• Satisfaction with extra 
check-ups of health 
condition 
• Satisfaction with the 
way information was 
disclosed 
• Satisfaction with the 
trial clinician as a 
person 
• Satisfaction with the 
way discomforts were 
experienced and effort 
had to be made during 
the trial 
• Satisfaction in relation 
to compliance with 
trial participation 
• Prior expectations and 
general attitudes toward 
medical care and 
research before entering 
a clinical trial have an 
impact on satisfaction 
with aspects of trial 
participation. 
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and one 19 in multinational countries (i.e., United States, 
Canada). 
 
Clinical trials and patient assessment instruments 
Patient assessment instruments. A number of instruments 
were used to evaluate patient satisfaction when enrolled in 
a clinical trial. Eight studies utilized investigator developed 
patient satisfaction instruments (i.e., Patient Experiences in 
Retinal Trials-PERT Questionnaire12; Systolic 
Hypertension in the Elderly Program Satisfaction/Attitude 
Questionnaire17; Research Study Participant Survey18; 
Gender, Race, and Clinical Experience Participant 
Survey19). Four of the studies13-15,20 did not report the 
names of the investigator developed patient satisfaction 
survey instrument and only one study used a widely used 
validated patient satisfaction instrument (i.e., Modified 
Client Satisfaction Questionnaire).16 
 
Number and domains of the patient satisfaction 
assessment instrument. The number of patient satisfaction 
items assessed ranged from a minimum of eight16 to a 
maximum of 60.14 In these studies, several patient 
satisfaction domains were assessed (e.g., entry into clinical 
trial decision-making,12-14,17,18 adherence,19,20 re-participate 
in a clinical trial or recommend12-20). Only five domains 
(i.e., clinical trial participant motivation, healthcare team 
interaction, knowledge and benefits of clinical trial 
participation, re-participate and recommend, overall 
impression of the clinical trial) were common across the 
nine studies.  
 
Clinical trial participant motivation 
While studies evaluating the motivation/satisfaction to 
participate in a clinical trial were excluded from our 
inclusion criteria, five of the nine studies that met our 
criteria examined this patient satisfaction domain. In one 
study,12 the reasons varied, but one of the most popular 
responses was that participants ‘wanted to contribute to 
medical science’. In another study,14 ‘contributing to 
research that can help others in the future’ achieved a 
median 9.7 on a scale from the lowest score of 0 to the 
highest score of 10. In another study,17 two of the most 
important reasons for joining the clinical trial were the 
desire to contribute to science and to improve health of 
others (i.e., 96%, and 96%, respectively). Moreover, in one 
study,19 the most common reason to participate in the 
clinical trial was the desire to contribute to something 
bigger/help others. 
 
Of the five studies, two included financial motivations. In 
one study,13 54.1% of the patients cited the purpose for 
participation was based on economic benefits and was 
reported as statistically significant (p < 0.001). In another 
study,18 49.6% of the patients reported the motivating 
reason for clinical trial participation was to earn study 
payment. 
 
Healthcare team interaction 
The encounters between the patient and the healthcare 
team were evaluated in four of the nine studies. The 
responses obtained were relatively positive and achieved 
high percentile ranks or percentages. In one study,12 93% 
of the patients thought the medical staff always treated 
them with courtesy and respect, 96% thought staff were 
always helpful and 86% felt, from their perspective, that 
the team always worked well together. In addition, the 
investigators reported that greater contact with the 
healthcare team may have improved patient outcomes in 
their study. In another study,15 the highest positive 
responses were related to patient-staff interactions, with 
80% indicating “strongly agree” for staff friendliness, 
75.6% for respect for patients and 77.2% time spent with 
patients, 66.7% for explaining their role in the study, and 
65.6% for answering questions fully. In one study,17 99.8% 
of the patients agreed the staff were friendly and 99.4% 
felt they provided good care. In another study,18 90.6% of 
the patients reported they felt the research staff were 
courteous and 89.7% felt they were professional. 
Moreover, in another study,20 94% of the patients were 
satisfied with the clinician as a person and had a positive 
attitude towards them and 97% reported trust and 
friendliness was important.  
 
Knowledge and benefits of clinical trial participation 
Four of the nine studies evaluated knowledge and benefits 
of trial participation. In one study,14 more than 80% 
reported that they had received sufficient and relevant 
information related to the clinical trial. In addition, the 
investigators suggested patients with adequate knowledge 
of their trial were less likely to experience regret in their 
decision to participate and potentially complete the study. 
In another study,18 80.4% of the patients reported they 
understood the possible benefit(s) involved with 
participating in a study. In another study,15 63.3% of the 
patients reported they were fully informed of the 
risks/benefits of clinical trial participation. Moreover, Chu 
et al. discussed the satisfaction of understanding the 
benefits of trial participation, which assists in participant 
satisfaction.13 
 
Re-participate and recommend 
While the one patient satisfaction domain of re-
participating and recommending a clinical trial was present 
in eight out of the nine studies, the responses related to 
this domain varied. In one study,12 77.5% of the patients 
reported they would volunteer for another trial. In another 
study,13 the mean score of participating in another clinical 
trial was 7.95 (SD, 2.05) on an 11-point Likert scale. In 
another study,20 88.9% of the respondents indicated they 
would volunteer again in a similar type of study. 
In terms of recommending another individual to a clinical 
trial, four of the eight studies evaluated this patient 
satisfaction domain. In one study,12 the majority of 
patients would recommend participation to another 
Patient satisfaction while enrolled in clinical trials: A literature review, Tantoy et al. 
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person. In another study,14 82% of the respondents 
answered they were positively inclined to recommend 
others to participate in cancer trials. Smailes et al. reported 
88.3% of patients in their study would recommend others 
to consider participation in a research study at the 
institution.18 In another study,19 96% of the patients on the 
trial would recommend participation in a clinical trial to 
others. Moreover, the means across the three study arms 
in one study,16 were reported as statistically significant (p 
<0.01) when the patients responded to the question if they 
would recommend the research program to a friend. 
 
While six of the eight studies reported relatively positive 
data, two studies reported low percentile rankings and/or 
non-statistically significant results. In one study,15 which 
evaluated the patient’s desire to participate in another 
study and encourage others to participate, the investigators 
reported low percentile ranks of 61.3% and 52.1%, 
respectively. While in one study,16 the mean scores were 
relatively high on a scale from 1 (worst) to 4 (best) when 
patients were asked if they would recommend the research 
program to a friend, the differences between the groups 
were not statistically significant. 
 
Overall impression of the clinical trial 
The overall impression of participation in a clinical trial 
was assessed in six studies. In one study,12 the patients’ 
overall impression of the clinical trial was mostly positive 
and 85% of the patients reported that taking part in the 
trial was important for their condition. Godskesen et al. 
reported 96% of the respondents in their study were 
satisfied with their participation in the clinical trial 14. In 
another study,18 87.9% of the patients strongly agreed that 
their overall experience was positive. 
 
In another study,13 the mean score for overall satisfaction 
with the clinical trial was 8.40 ± 1.60 on a scale from 0 
(not at all) to 10 (completely agree). In another study,16 
overall satisfaction scores were high, with means near or 
above a value of 3 on a scale from 1 (worst) to 4 (best). 
Moreover, in another study,15 the investigators reported 
participant intention to seek future medical care at the 
facility and enjoyment of their visits were positive and 




This review is the first to summarize the findings from 
studies that examined patients’ experiences while enrolled 
in clinical trials utilizing a widely used, validated 
instrument. Across the nine studies included in this review, 
only five patient satisfaction domains were common 
among the articles. Given that >70% of the general 
population believe in opportunities to participate in clinical 
trials21 and the importance of positive trial participation, it 
is disappointing that only nine studies have systematically 
evaluated patient experiences while enrolled in a clinical 
trial. 
 
Clinical trials and patient assessment instruments 
Of the nine studies identified for this review, only one 
study used a widely used validated patient satisfaction 
instrument (i.e., Modified Client Satisfaction 
Questionnaire).16 This is not surprising given the limited 
number of valid and reliable patient satisfaction 
instruments developed for clinical trials. In addition, a 
salient question remains regarding the identification of the 
most appropriate patient satisfaction instruments to use 
for patients enrolled in clinical trials. Findings from this 
review suggest that little is known about the most 
appropriate patient satisfaction instrument to utilize and 
how to apply the domains of these existing instruments in 
patients who enroll in a clinical trial. Moreover, qualitative 
studies are warranted to identify appropriate patient 
satisfaction domains associated with clinical trials. 
 
Clinical trial participant motivation  
Altruism was the most popular and/or main motivation 
reported for clinical trial participation. This finding is 
consistent with studies that have evaluated personal 
motivations for clinical trial participation and found that 
participation is driven by a desire to benefit others, which 
is an important factor for participation.22-24 In addition, the 
potential for improving the chances of one’s 
health/condition were reported in the same four studies 
and is consistent with studies that have examined personal 
health factors or seeking best treatment options as a 
contributing factor to participation.25,26  
 
A surprising finding is the limited number of responses to 
seek out financial gains when participating in a 
pharmacological medical intervention clinical trial. 
Empirical evidence suggests that reasonable financial 
reimbursement is utilized by many studies as an effective 
strategy to improve patient recruitment, retention rates 
and participation.27 For example, in one study,28 financial 
incentives were implemented and an increase in patients’ 
enrollment was reported from 24.7% to 31.6%, 
respectively. In addition, two systematic reviews26,29 found 
financial incentive/reward was the greatest influencing 
factor and/or motivation for patients to engage in clinical 
trials. While debates both for and against financial 
incentives have been cited in the literature30 and significant 
regulatory advancements have been made to ensure that 
the ethical application of financial compensation to 
patients when participating in clinical trials is not 
compromised, additional studies are needed to further 
evaluate the role of financial incentives in clinical trials and 
their potential role in patient satisfaction.7 
 
Healthcare team interaction 
The studies that evaluated patient satisfaction with the 
healthcare team encounter domain were relatively positive. 
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These results are consistent with other studies evaluating 
this patient satisfaction domain. For example, in one 
study,31 the patients reported trust in the hospital and trust 
in the doctor were motivating factors for participation in a 
clinical trial. In addition, these findings are consistent with 
two systematic reviews32,33 that evaluated the patient-
clinician therapeutic relationship in randomized clinical 
trials are seen as a positive influence in clinical trials 
participation. 
 
In terms of the effect of the patient-clinical relationship to 
healthcare outcomes, only one study reported that less 
adherence to treatment medication was associated with not 
being very comfortable with study site and staff.19 This 
finding is consistent with one study that reported the 
estimate of the overall effective size of the healthcare team 
encounter as small (d = .11), but statistically significant (p 
= .02).32 While the effect size for the influence of the 
clinical relationship on health outcomes in this study was 
small, the review utilized objective and validated subjective 
medical outcomes to assess the relationship, which is more 
reflective of the patients’ experience. Moreover, it may be 
salient for researchers to de-emphasize accuracy in 
performance of key study activities and shift the focus on 
the importance of participation and completion of 
research visits to ensure protocol treatment compliance.16 
 
Knowledge and benefits of clinical trial participation 
Only four studies13-15,18 evaluated knowledge and benefits 
of clinical trial participation. While the data reported 
suggests positive associations between a patient’s 
knowledge and understanding the benefits of clinical trial 
participation, it was not clear if overall satisfaction was 
sustainable as data were collected at various time points 
across the studies and were cross-sectional. In addition, 
researchers from one study suggested that participating in 
a clinical trial can show a positive association to 
understanding benefits and knowledge of clinical trial 
participation.34 Given that four studies evaluated for this 
association between knowledge and benefits of clinical trial 
participation, and that those patient satisfaction scores 
were positive, a more detailed evaluation is warranted to 
identify if additional information and assessments yield an 
increase in patient satisfaction throughout enrollment in a 
clinical trial. 
 
Re-participate and recommend 
Six studies reported relatively high responses to re-
participate or recommend others to participate in clinical 
trials. This finding is not surprising as patients whose 
physicians are also investigators become aware of clinical 
trials and, subsequently, enroll in these studies and are 
willing to re-participate.21,35 In addition, the amount and 
type of information obtained has been associated with 
decision making regarding participation and re-
participation in clinical trials.5 In terms of recommending 
others to participate, studies have focused on the 
physician’s motivations and/or communication to 
recommend,36,37 but there are limited studies that have 
reported on patients who participate in clinical trials and 
their desire to re-participate and/or recommend others to 
participate.38 While these studies did not evaluate decision 
making related to recommending others to participate 
and/or re-participate exploring these processes further 
may enhance clinical trial participation and patient 
satisfaction.35 
 
Overall impression of the clinical trial 
Six studies12-16,18 evaluated the overall impression of the 
patients’ participation in a clinical trial. While positive 
responses were reported, only one study16 evaluated the 
patients’ experience with a widely used, validated patient 
satisfaction instrument. However, the instrument used in 
this study was developed to assess consumer/client 
satisfaction with health, human services, governmental and 
public benefit programs and services.39 No studies utilized 
a widely used, validated patient satisfaction instrument 
before, during, or following medical intervention 
treatments. 
 
One of the primary purposes of this review was to 
evaluate the associations between patient satisfaction while 
enrolled in clinical trials. While protocol compliance and 
outcomes may be related to a patient’s satisfaction with 
aspects of trial participation,20 only one study addressed 
this question. In this study,19 the associations of patient 
satisfaction responses with clinical outcomes were 
evaluated. Therefore, while interest in participating in 
clinical trials remains high and the increasing focus on the 
patient experience remains salient in healthcare, additional 
research is warranted to determine if current existing 
instruments will assist in understanding this subset of 




Given the importance of patient satisfaction surveys and 
their link to hospital value-based purchasing and 
reimbursement, as well as healthcare outcome metrics, 
additional studies focused on this subset of patients 
enrolled in clinical trials is warranted.42 In addition, only 
one study evaluated patient satisfaction while enrolled in a 
clinical trial utilizing a widely used, validated non-research 
patient satisfaction instrument. Future studies need to 
focus on domains associated with clinical trial participation 
and look beyond the current patients’ general expectations 
about healthcare accessibility, facilities, healthcare team 
clinical skills, and their ability to focus and listen to the 
patients’ concerns.42 Moreover, data obtained from studies 
focused on the actual experiences of patients enrolled in 
clinical trials may increase patient satisfaction with their 
clinical trial experience, which may assist in ameliorating 
patients choosing to prematurely discontinue and/or not 
Patient satisfaction while enrolled in clinical trials: A literature review, Tantoy et al. 
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